Signal transduction through the cAMP-dependent protein kinase

Temporal cellular events responsible for hormonal activation of responses mediated by the cAMP-dependent protein kinase (PKA) have been studied in living cells. By selectively perturbing molecular function of Gs, the catalytic subunit of PKA (C), or the nuclear factor CREB, in cells through microinjection of inhibitory agents specific for these molecules or activated forms of these molecules, we have obtained evidence for a requirement for the function of each of these molecules in the hormonal stimulation of cAMP-regulated genes. Moreover, by introducing fluorescently labeled PKA subunits into these cells as molecular tracers, or by immunofluorescence of C subunit, we have observed biological translocation of C subunit from the cytoplasm to the nucleus during transcriptional activation and a quenching of this by the inhibitor molecule, PKI. The implications of these cellular and molecular events in the signal transduction of hormonal responses are discussed.

[1]  S. Taylor,et al.  A point mutation abolishes binding of cAMP to site A in the regulatory subunit of cAMP-dependent protein kinase. , 1988, The Journal of biological chemistry.

[2]  M. Uhler,et al.  Expression of cDNAs for two isoforms of the catalytic subunit of cAMP-dependent protein kinase. , 1987, The Journal of biological chemistry.

[3]  J. Feramisco,et al.  Inhibition of thyrotropin-induced DNA synthesis in thyroid follicular cells by microinjection of an antibody to the stimulatory G protein of adenylate cyclase, Gs. , 1992, The Journal of biological chemistry.

[4]  W. Simonds,et al.  Gi2 mediates alpha 2-adrenergic inhibition of adenylyl cyclase in platelet membranes: in situ identification with G alpha C-terminal antibodies. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Uhler,et al.  Analysis of the cAMP-dependent protein kinase system using molecular genetic approaches. , 1988, Recent progress in hormone research.

[6]  E. Krebs,et al.  Activation of protein kinase by physiological concentrations of cyclic AMP. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Nigg,et al.  Cyclic-AMP-dependent protein kinase type II is associated with the Golgi complex and with centrosomes , 1985, Cell.

[8]  M. Uhler,et al.  Isolation and characterization of cDNA clones for an inhibitor protein of cAMP-dependent protein kinase. , 1991, The Journal of biological chemistry.

[9]  M. Montminy,et al.  Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 , 1989, Cell.

[10]  S. Taylor,et al.  Dynamics of the distribution of cyclic AMP-dependent protein kinase in living cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Hagiwara,et al.  Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB , 1992, Cell.

[12]  W. Simonds,et al.  Receptor and effector interactions of Gs Functional studies with antibodies to the αs carboxyl‐terminal decapeptide , 1989, FEBS letters.

[13]  E. Krebs,et al.  Phosphorylation-dephosphorylation of enzymes. , 1979, Annual review of biochemistry.

[14]  P. Laurberg,et al.  Hyperfunctioning thyroid nodules. , 1991, Thyroidology.

[15]  J. Habener,et al.  Cyclic‐AMP‐responsive transcriptional activation of CREB‐327 involves interdependent phosphorylated subdomains. , 1990, The EMBO journal.

[16]  J. Frost,et al.  Rapid transcriptional assay for the expression of two distinct reporter genes by microinjection. , 1993, DNA and cell biology.

[17]  E. Nigg,et al.  Rapid and reversible translocation of the catalytic subunit of cAMP‐dependent protein kinase type II from the Golgi complex to the nucleus. , 1985, The EMBO journal.

[18]  U. Walter,et al.  Regulation of the cellular and subcellular concentrations and distribution of cyclic nucleotide-dependent protein kinases. , 1984, Advances in cyclic nucleotide and protein phosphorylation research.

[19]  A. Nairn,et al.  Protein phosphatases: recent progress. , 1991, Advances in second messenger and phosphoprotein research.

[20]  E. Krebs,et al.  Activation ofProtein KinasebyPhysiological Concentrations ofCyclic AMP , 1974 .

[21]  M. Kuettel,et al.  Localization of nuclear subunits of cyclic AMP-dependent protein kinase by the immunocolloidal gold method , 1985, The Journal of cell biology.

[22]  M. Montminy,et al.  Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB , 1988, Nature.

[23]  E. Borrelli,et al.  CREM gene: Use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription , 1991, Cell.

[24]  E. Sutherland,et al.  Formation of a cyclic adenine ribonucleotide by tissue particles. , 1958, The Journal of biological chemistry.

[25]  H. Bourne,et al.  GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours , 1989, Nature.

[26]  D. Barford.  Protein Phosphatases , 2004, Topics in Current Genetics.

[27]  A. Smith,et al.  Molecular cloning of a rat testis form of the inhibitor protein of cAMP-dependent protein kinase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  B. Caillou,et al.  Detection of activated ras oncogenes in human thyroid carcinomas. , 1988, Oncogene.

[29]  J. Scott,et al.  Type II regulatory subunit dimerization determines the subcellular localization of the cAMP-dependent protein kinase. , 1990, The Journal of biological chemistry.

[30]  Susan S. Taylor,et al.  Fluorescence ratio imaging of cyclic AMP in single cells , 1991, Nature.

[31]  G. Giannattasio,et al.  Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas , 1987, Nature.

[32]  M. Montminy,et al.  Induction of a cyclic AMP-responsive gene in living cells requires the nuclear factor CREB , 1991, Molecular and cellular biology.